Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The presence of cervical musculoskeletal impairment is not specific to cervicogenic headache but other various frequent intermittent headache types (i.e. migraine and tension-type headache) in the elderly population. There has been no trial to date which has investigated the effectiveness of physiotherapy treatment specifically for older persons with various types of headache with associated neck pain and cervical musculoskeletal impairment. Thus, the purpose of study investigate the efficacy of physiotherapy treatment for older persons who have headache concomitant with neck pain and musculoskeletal impairment
Headache is a common health problem that affects quality of life in an older population and imposes substantial economic costs. Headache changes with age. Features of headache become less typical and neck pain is more frequently associated with headache in older persons. We recently demonstrated that the presence of cervical musculoskeletal impairment is not specific to cervicogenic headache (headache caused by the neck). Rather it was present in various frequent intermittent headache types in elders when compared to elders without headache. Changes in headache characteristics with age play an important role not only in diagnosis but also in treatment choice. Impairment in cervical musculoskeletal function found in older persons with headache has implications for headache management choices as the evidence indicates that physiotherapy management methods such as manual therapy and therapeutic exercise are an effective management approach for headache associated with the neck. Physiotherapy treatment would be a safe therapeutic option and may have a beneficial effect for elders with headache who have neck pain and concomitant cervical musculoskeletal dysfunction. This is particularly relevant as there are widespread concerns about medication overuse, adverse drug events and drug interactions in older persons. The effective management of older persons with headache in particular of those with atypical features of headache remains a challenge. Physiotherapy is indicated in those older persons diagnosed with cervicogenic headache but could also be adjunct treatment for those with cervical musculoskeletal signs who are suspected of having transitional headache. At present, there has been no trial to date which has investigated the effectiveness of physiotherapy treatment specifically for older persons with various types of headache with associated neck pain and cervical musculoskeletal impairment. A clinical trial of treatment of cervical musculoskeletal impairment in older persons with various headache types may help guide management of headache in attempts to lesson medication use and cost in this population. Physiotherapy management may be a worthy treatment option particularly in older persons with headache who do not respond well to medication.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Usual care intervention | Experimental | Primary care as required including medication |
|
| Physiotherapy treatment | Experimental | Exercise and manipulative therapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Usual care intervention | Other | The usual care intervention will include appropriate primary care as required including medication |
|
| Measure | Description | Time Frame |
|---|---|---|
| Headache frequency | The number of headache frequency in the past week | Change from baseline in headache frequency at week 11 and 6 months after intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Headache intensity | An average intensity in the past week will be rated on a 1-10 VAS | Change from baseline in headache intensity at week 11 and 6 months after intervention |
| Headache duration | The number of hours of headache in the past week |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sureeporn Uthaikhup, Ph.D. | Department of Physical Therapy, Faculty of Associated Medical Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Physical Therapy, Faculty of Associated Medical Sciences | Chiang Mai | Thailand |
Not provided
| ID | Term |
|---|---|
| D006261 | Headache |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Physiotherapy treatment | Other | Exercise and manipulative therapy treatment for 10 weeks:The treatment intervention consists of two visits per week for the first four weeks (8 treatments) and one visit per week for the last six weeks (6 treatments) |
|
| Change from baseline in headache duration at week 11 and 6 months after intervention |
| Neck pain intensity | Intensity of neck pain will be measured using a 1-10 VAS | Change from baseline in neck pain intensity at week 11 and 6 months after intervention |
| Neck pain and disability | Neck pain and disability will be measured using neck disability index (NDI-Thai version) | Change from baseline in neck pain and disability at week 11 and 6 months after intervention |
| Quality of life | The Quality of life will be measured using SF-36 (Thai version) | Change from baseline in quality of life at week 11 and 6 months after intervention |
| Medication intake | type and dose of all medications taken by subjects will be recorded one week at baseline and prior to follow-up points on a medication diary | Change from baseline in medication intake at week 11 and 6 months after intervention |
| Global assessment of treatment benefit | Patients perceived benefit of treatment will be measured on a scale from 0 (no benefit) to 10 (maximum benefit) | Changes from baseline in global assessment of treatment benefit at week 11 and 6 months after intervention |
| D001519 | Behavior |